Kelvin Stott

Amporin Pharmaceuticals AG is a Swiss biotech startup developing a breakthrough new class of small molecule drugs that can uniquely repair the holes in cell membranes caused by misfolded proteins, allowing cells to fully recover and restore homeostasis. Already with preliminary animal data demonstrating complete reversal of Alzheimer’s and Parkinson’s disease with a single oral dose in 2 established mouse models, our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease and ALS.